News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Protein ‘postcodes’ point to new targets for cancer treatment
Scientists have devised a new technique that establishes the ‘postcode’ for proteins within cancer cells, as a faster, more accurate way of identifying signals that are driving cancer growth.
ICR and Imperial College London launch the Cancer Research Centre of Excellence
The Institute of Cancer Research and Imperial College London have marked the start of a new joint partnership with the launch of the Cancer Research Centre of Excellence (CRCE) in London.
Good news as cancer patients will get access to more treatments after price drops
Pharmaceutical companies have lowered the prices of 14 key cancer medicines as part of a review by NICE of the old Cancer Drugs Fund (CDF).
Experimental drug could prevent cancer DNA repair to boost radiotherapy effects
Treating bladder and head-and-neck cancers with an experimental drug called CCT244747 makes radiotherapy more successful at killing them, scientists have discovered.
ICR partners in a new -180°C ‘cryo-EM’ machine
A new £3m grant from Wellcome to a consortium led by scientists at Imperial College London and The Institute of Cancer Research, London, will help to purchase a state-of-the-art cryo-electron microscopy machine.
Five stunning scientific images of our cancer research
Researchers at the ICR were challenged to capture in a single image their ground-breaking work making the discoveries that defeat cancer.
New molecular ‘building block’ to aid drug discovery
Scientists have discovered how to make a synthetic molecule that could be a key building block in the production of future cancer drugs.
-and-actin-(green)-julia-sero-the-icr-2011.jpg?sfvrsn=14c02140_2 "Breast epithelial cells stained for DNA (magenta) and actin (green). Julia Sero / the ICR, 2011")
ICR team is part of winning consortium for Cancer Research UK ‘Grand Challenge’
Scientists from The Institute of Cancer Research, London, are part of a consortium that has won one of the first wave of ‘Grand Challenge’ grants from Cancer Research UK.
Non-profit drug development could cut cost of cancer medicines
Universities should work with new forms of commercial partner to take their own cancer drugs to market and drive down the ‘spiralling’ cost of new medicines, leading experts propose.
Immune system genes linked to most common type of leukaemia
People who inherit genetic variants affecting the function of their immune system are at increased risk of developing the most common form of leukaemia, a major new study reveals.
The ICR responds to decision by NICE not to recommend palbociclib
The Institute of Cancer Research, London, has expressed disappointment that the breast cancer drug palbociclib will not be made available to patients and is calling for urgent discussions to reduce the price of the drug.
Cell shape ‘maps’ could point to new cancer treatments
Scientists have created a ‘map’ linking the shape of breast cancer cells to the activation of their genes, which could point towards new treatments and help improve the effectiveness of immunotherapies.
